Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
6.0K
Cancer02:18

Cancer

55.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.8K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

7.2K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.1K
3.1K
Cancer Prevention02:59

Cancer Prevention

8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

The effect of gender on nephrectomy perioperative outcomes: a national survey.

The Canadian journal of urology·2012
Same author

Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades.

International journal of urology : official journal of the Japanese Urological Association·2012
Same author

Prostate saturation biopsy following a first negative biopsy: state of the art.

Urologia internationalis·2012
Same author

Diagnosis and treatment of bladder endometriosis: state of the art.

Urologia internationalis·2012
Same author

Effects of once-daily tadalafil on treatment satisfaction, psychosocial outcomes, spontaneous erections, and measures of endothelial function in men with erectile dysfunction but naive to phosphodiesterase type 5 inhibitors.

Journal of andrology·2012
Same author

Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.

International journal of urology : official journal of the Japanese Urological Association·2012
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

Lancet (London, England)·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Apr 4, 2026

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

799

Cáncer de riñón

Umberto Capitanio1, Francesco Montorsi2

  • 1Department of Urology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Lancet (London, England)
|August 31, 2015
PubMed
Resumen
Este resumen es generado por máquina.

El diagnóstico y el tratamiento del carcinoma de células renales (CCR) han evolucionado rápidamente, mejorando las tasas de supervivencia. Los avances incluyen vigilancia activa, cirugía mínimamente invasiva y terapias dirigidas, aunque persisten los desafíos en la enfermedad avanzada.

Más Videos Relacionados

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

17.3K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

Videos de Experimentos Relacionados

Last Updated: Apr 4, 2026

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

799
Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

17.3K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

Área de la Ciencia:

  • En el campo de la oncología
  • Urología

Sus antecedentes:

  • La incidencia del carcinoma de células renales (CCR) está aumentando, pero las tasas de supervivencia han mejorado significativamente.
  • Es común el aumento del diagnóstico incidental de CCR pequeños e indolentes.
  • La enfermedad localmente avanzada y metastásica siguen siendo desafíos significativos.

Objetivo del estudio:

  • Revisar los avances recientes en el diagnóstico y tratamiento del carcinoma de células renales.
  • Destacar las estrategias de tratamiento en evolución para el CCR localizado y avanzado.
  • Identificar las incertidumbres actuales y las direcciones futuras de la investigación en el cuidado del CCR.

Principales métodos:

  • Revisión de estudios clínicos y directrices recientes.
  • Análisis de las tendencias en el diagnóstico y las modalidades de tratamiento del CCR.
  • Síntesis de datos sobre las técnicas quirúrgicas, la vigilancia y las terapias sistémicas.

Principales resultados:

  • Mayor adopción de vigilancia activa y técnicas quirúrgicas que ahorran nefronas (por ejemplo, cirugía asistida por robots).
  • La creciente popularidad de procedimientos mínimamente invasivos como la ablación térmica para tumores pequeños.
  • Mejorar los resultados para el CCR avanzado a través de estrategias integradas que combinan cirugía y fármacos biológicos específicos.

Conclusiones:

  • Los avances significativos en el manejo del CCR han llevado a una mejor supervivencia, especialmente en las primeras etapas de la enfermedad.
  • Los enfoques integrados que combinan la eliminación quirúrgica con terapias sistémicas específicas mejoran el cuidado del CCR avanzado.
  • La investigación en curso es crucial para abordar los desafíos restantes y mejorar aún más los resultados de los pacientes con carcinoma de células renales.